$4888 | SAVE $862 | Single User
$9775 | SAVE $1,725 | Site License
$14663 | SAVE $2,587 | Enterprise License

Ulcerative Colitis - Market Insights, Epidemiology and Market Forecast – 2025

Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast – 2025
[Lowest Price Guaranteed: $4,888]

Published by Delve Insight: 10 Oct 2017 | 139161 | In Stock
Related Topics: Ulcerative Colitis

Introduction

DelveInsight’s “Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025.

This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast. It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast for 7 major markets. The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast market, as well as treatment algorithm, current treatments & advancements are included.

The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast, providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast 7MM market size is estimated to be USD XX by 2025. The DelveInsight Report will help in enhanced understanding of the Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

• Understanding historical and forecasted epidemiological data for Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast covering 7MM from 2015-2025.

• Segment level epidemiology and market split for Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast.

• The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast.

• The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast market trends.

• Thorough market distribution based on market share for Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast.

Reasons to buy:

• The report will help in developing business strategies by understanding trends shaping and driving the Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast market.

• To understand the future market competition in the Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast market and Insightful review of the key market drivers and barriers.

• Organize sales and marketing efforts by identifying the best opportunities for Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

• Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

Table of Contents
for Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast – 2025

  • 1. Report Introduction

    2. Ulcerative Colitis (UC) Market Overview at a Glance

    2.1. Total Market Share Distribution of Ulcerative Colitis (UC) for 7 MM in 2016

    2.2. Total Market Share Distribution of Ulcerative Colitis (UC) for 7 MM in 2025

    3. Ulcerative Colitis (UC)

    3.1.1. Overview

    3.1.2. Symptoms

    3.1.3. Pathophysiology

    3.1.4. Staging

    3.1.5. Diagnosis

    3.1.6. Treatment

    4. Epidemiology and Patient Population

    4.1.1. United States

    4.1.1.1. Diagnosed Cases of Ulcerative Colitis (UC) in United States

    4.1.2. Germany

    4.1.2.1. Diagnosed Cases of Ulcerative Colitis (UC) in Germany

    4.1.3. France

    4.1.3.1. Diagnosed Cases of Ulcerative Colitis (UC) in France

    4.1.4. Italy

    4.1.4.1. Diagnosed Cases of Ulcerative Colitis (UC) in Italy

    4.1.5. Spain

    4.1.5.1. Diagnosed Cases of Ulcerative Colitis (UC) in Spain

    4.1.6. United Kingdom

    4.1.6.1. Diagnosed Cases of Ulcerative Colitis (UC) in United Kingdom

    5. Treatment Algorithm

    5.1.1. Treatment Guidelines/Practices

    6. Marketed Drugs for Ulcerative Colitis (UC)

    6.1. Drug 1: Company A

    6.1.1. Drug Description

    6.1.2. Mechanism of Action

    6.1.3. Regulatory Milestones

    6.1.4. Advantages & Disadvantages

    6.1.5. Safety and Efficacy

    6.1.6. Product Profile

    6.1.7. Patent Status

    6.2. Drug 2: Company B

    6.2.1. Drug Description

    6.2.2. Mechanism of Action

    6.2.3. Regulatory Milestones

    6.2.4. Advantages & Disadvantages

    6.2.5. Safety and Efficacy

    6.2.6. Product Profile

    6.2.7. Patent Status

    7. Emerging Therapies

    7.1. Drug 3: Company C

    7.1.1. Description

    7.1.2. Regulatory Milestones

    7.1.3. Advantages & Disadvantages

    7.1.4. Product Profile

    7.1.5. Launch Date

    7.1.6. Clinical Development

    7.1.7. Clinical Pipeline Activity

    7.1.8. Ongoing Trials Information

    7.1.9. Clinical Trial by Phase

    7.2. Drug 4: Company B

    7.2.1. Description

    7.2.2. Regulatory Milestones

    7.2.3. Advantages & Disadvantages

    7.2.4. Product Profile

    7.2.5. Launch Date

    7.2.6. Clinical Development

    7.2.7. Clinical Pipeline Activity

    7.2.8. Ongoing Trials Information

    7.2.9. Clinical Trial by Phase

    8. Overview of Total Ulcerative Colitis (UC) Market (2016 & 2025)

    9. Ulcerative Colitis (UC): Country-Wise Market Analysis

    9.1. United States

    9.1.1. Historical Market Size (2015-2016)

    9.1.2. Forecasted Market Size (2017-2025)

    9.2. Germany Market Size

    9.2.1. Historical Market Size (2015-2016)

    9.2.2. Forecasted Market Size (2017-2025)

    9.3. France Market Size

    9.3.1. Historical Market Size (2015-2016)

    9.3.2. Forecasted Market Size (2017-2025)

    9.4. United Kingdom Market Size

    9.4.1. Historical Market Size (2015-2016)

    9.4.2. Forecasted Market Size (2017-2025)

    9.5. Spain Market Size

    9.5.1. Historical Market Size (2015-2016)

    9.5.2. Forecasted Market Size (2017-2025)

    9.6. Italy Market Size

    9.6.1. Historical Market Size (2015-2016)

    9.6.2. Forecasted Market Size (2017-2025)

    9.7. Japan Market Size

    9.7.1. Historical Market Size (2015-2016)

    9.7.2. Forecasted Market Size (2017-2025)

    10. Market Drivers

    11. Market Restraints

    12. Appendix

    13. Report Methodology

    14. Consulting Services

    15. Disclaimer

    16. About DelveInsight

    List of Tables

    Table 1: Diagnosed Cases Ulcerative Colitis (UC) in United States (2015-2025)

    Table 2: Diagnosed Cases Ulcerative Colitis (UC) in Germany (2015-2025)

    Table 3: Diagnosed Cases Ulcerative Colitis (UC) in France (2015-2025)

    Table 4: Diagnosed Cases Ulcerative Colitis (UC) in United Kingdom (2015-2025)

    Table 5: Diagnosed Cases Ulcerative Colitis (UC) in Spain (2015-2025)

    Table 6: Diagnosed Cases Ulcerative Colitis (UC) in Italy (2015-2025)

    Table 7: Diagnosed Cases Ulcerative Colitis (UC) in Japan (2015-2025)

    Table 8: List of Marketed Drugs for Ulcerative Colitis (UC)

    Table 9: List of Pipeline Phase III Drugs for Ulcerative Colitis (UC)

    Table 10: Drug 1, Clinical Trials by Zone, 2017

    Table 11: Clinical Trials by Trial status, 2017

    Table 12: Drug 2, Clinical Trials by Zone, 2017

    Table 13: Clinical Trials by Trial status, 2017

    Table 14: Drug 3, Clinical Trials by Zone, 2017

    Table 15: Clinical Trials by Trial status, 2017

    Table 16: United States Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Table 17: Germany Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Table 18: France Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Table 19: United Kingdom Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Table 20: Spain Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Table 21: Italy Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Table 22: Japan Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    List of Figures

    Figure 1: Diagnosed Cases Ulcerative Colitis (UC) in United States (2015-2025)

    Figure 2: Diagnosed Cases Ulcerative Colitis (UC) in Germany (2015-2025)

    Figure 3: Diagnosed Cases Ulcerative Colitis (UC) in France (2015-2025)

    Figure 4: Diagnosed Cases Ulcerative Colitis (UC) in United Kingdom (2015-2025)

    Figure 5: Diagnosed Cases Ulcerative Colitis (UC) in Spain (2015-2025)

    Figure 6: Diagnosed Cases Ulcerative Colitis (UC) in Italy (2015-2025)

    Figure 7: Diagnosed Cases Ulcerative Colitis (UC) in Japan (2015-2025)

    Figure 8: List of Marketed Drugs for Ulcerative Colitis (UC)

    Figure 9: List of Pipeline Phase III Drugs for Ulcerative Colitis (UC)

    Figure 10: Drug 1, Clinical Trials by Zone (%), 2017

    Figure 11: Clinical Trials by Trial status, 2017

    Figure 12: Drug 2, Clinical Trials by Zone (%), 2017

    Figure 13: Clinical Trials by Trial status, 2017

    Figure 14: Drug 3, Clinical Trials by Zone (%), 2017

    Figure 15: Clinical Trials by Trial status, 2017

    Figure 16: United States Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Figure 17: Germany Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Figure 18: France Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Figure 19: United Kingdom Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Figure 20: Spain Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Figure 21: Italy Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Figure 22: Japan Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

    Ulcerative Colitis (UC) Market (7MM)

    Ulcerative Colitis (UC) Market forecasting

    Ulcerative Colitis (UC) Sales forecasting

    Ulcerative Colitis (UC) Market segments

    Ulcerative Colitis (UC) Epidemiology

    Ulcerative Colitis (UC) Pipeline products and technologies

    Ulcerative Colitis (UC) Competitive landscape

    Ulcerative Colitis (UC) SWOT analysis

    Ulcerative Colitis (UC) Market Driver’s and barriers

    Ulcerative Colitis (UC) Key Companies and Funding

List Of Tables
in Ulcerative Colitis - Market Insights, Epidemiology and Market Forecast – 2025

Table 1: Diagnosed Cases Ulcerative Colitis (UC) in United States (2015-2025)

Table 2: Diagnosed Cases Ulcerative Colitis (UC) in Germany (2015-2025)

Table 3: Diagnosed Cases Ulcerative Colitis (UC) in France (2015-2025)

Table 4: Diagnosed Cases Ulcerative Colitis (UC) in United Kingdom (2015-2025)

Table 5: Diagnosed Cases Ulcerative Colitis (UC) in Spain (2015-2025)

Table 6: Diagnosed Cases Ulcerative Colitis (UC) in Italy (2015-2025)

Table 7: Diagnosed Cases Ulcerative Colitis (UC) in Japan (2015-2025)

Table 8: List of Marketed Drugs for Ulcerative Colitis (UC)

Table 9: List of Pipeline Phase III Drugs for Ulcerative Colitis (UC)

Table 10: Drug 1, Clinical Trials by Zone, 2017

Table 11: Clinical Trials by Trial status, 2017

Table 12: Drug 2, Clinical Trials by Zone, 2017

Table 13: Clinical Trials by Trial status, 2017

Table 14: Drug 3, Clinical Trials by Zone, 2017

Table 15: Clinical Trials by Trial status, 2017

Table 16: United States Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Table 17: Germany Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Table 18: France Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Table 19: United Kingdom Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Table 20: Spain Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Table 21: Italy Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Table 22: Japan Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

List Of Figures, Charts and Diagrams
in Ulcerative Colitis - Market Insights, Epidemiology and Market Forecast – 2025

Figure 1: Diagnosed Cases Ulcerative Colitis (UC) in United States (2015-2025)

Figure 2: Diagnosed Cases Ulcerative Colitis (UC) in Germany (2015-2025)

Figure 3: Diagnosed Cases Ulcerative Colitis (UC) in France (2015-2025)

Figure 4: Diagnosed Cases Ulcerative Colitis (UC) in United Kingdom (2015-2025)

Figure 5: Diagnosed Cases Ulcerative Colitis (UC) in Spain (2015-2025)

Figure 6: Diagnosed Cases Ulcerative Colitis (UC) in Italy (2015-2025)

Figure 7: Diagnosed Cases Ulcerative Colitis (UC) in Japan (2015-2025)

Figure 8: List of Marketed Drugs for Ulcerative Colitis (UC)

Figure 9: List of Pipeline Phase III Drugs for Ulcerative Colitis (UC)

Figure 10: Drug 1, Clinical Trials by Zone (%), 2017

Figure 11: Clinical Trials by Trial status, 2017

Figure 12: Drug 2, Clinical Trials by Zone (%), 2017

Figure 13: Clinical Trials by Trial status, 2017

Figure 14: Drug 3, Clinical Trials by Zone (%), 2017

Figure 15: Clinical Trials by Trial status, 2017

Figure 16: United States Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Figure 17: Germany Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Figure 18: France Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Figure 19: United Kingdom Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Figure 20: Spain Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Figure 21: Italy Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Figure 22: Japan Market Size of Ulcerative Colitis (UC) in USD, Million (2015-2025)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

139161 | DIMI0345

Number of Pages

70

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Ulcerative Colitis - Pipeline Review, H1 2017
Ulcerative Colitis - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical an...
09 May 2017 by Global Markets Direct USD $1,700 (normally
USD $2,000)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2017
The Global Ulcerative Colitis Partnering Terms and Agreements since 2010 report provides understandi...
01 Apr 2017 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2017
The Global Ulcerative Colitis Partnering Terms and Agreements since 2010 report provides understandi...
01 Feb 2017 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Ulcerative Colitis Global Clinical Trials Review, H2, 2016
Ulcerative Colitis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report,...
28 Sep 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Ulcerative Colitis: KOL Insight
Are UC biosimilars a real or perceived threat to branded drugs?Ulcerative colitis (UC) treatment is ...
01 Sep 2016 by FirstWord Pharma USD $6,715 (normally
USD $7,900)
More Info
SAVE 15% today! Ulcerative Colitis: Update Bulletin [Feb 2016]
IntroductionGain new KOL insights on the latest events happening in Ulcerative Colitis. Topics cover...
01 Feb 2016 by FirstWord Pharma USD $846 (normally
USD $995)
More Info
SAVE 15% today! Ulcerative Colitis: KOL Insight
Introductionipeline drugs are poised to reshape the way doctors treat ulcerative colitis (UC). But w...
01 Dec 2015 by FirstWord Pharma USD $6,715 (normally
USD $7,900)
More Info
SAVE 15% today! Ulcerative Colitis: KOL Insight
IntroductionThe Ulcerative Colitis (UC) treatment market is already undergoing radical change as new...
03 Dec 2014 by FirstWord Pharma USD $6,715 (normally
USD $7,900)
More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Download Free Report Summary PDF

Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Forecast – 2025 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...